Skip to content

Development and Characterization of β-Cyclodextrin and Methotrexate Inclusion Complex-Based Nanogel for the Management of Rheumatoid Arthritis

Jul 2026 · BioNanoScience · Vol 16 · 1 citation · ⚡ 1 influential · 36 references

TL;DR

A nanoemulsion based gel loaded with the β-CD-MTX inclusion complex provides a hopeful approach to enhance topical MTX delivery, improves therapeutic efficacy, and reduces systemic side effects, thereby addressing important limitations of traditional RA therapy.

View source

Similar papers

Open access Oct 2026

DEVELOPMENT AND OPTIMIZATION OF METHOTREXATE-LOADED GLYCEROSOMES USING BOX–BEHNKEN DESIGN FOR ENHANCED TOPICAL DRUG DELIVERY

Methotrexate is an effective disease-modifying antirheumatic drug (DMARD) widely used in the management of rheumatoid arthritis and psoriasis; however, its conventional administration is associated with poor patient compliance and systemic adverse effects. The present study aimed to develop and optimize methotrexate-lo...

Shilpa Hanamant Jagtap, Dhyanendra Singh Baghel · 0 citations
Sep 2026

Nanostructured Cubosomal Gels for Targeted Drug Delivery in Rheumatoid Arthritis: Advances in Nanomedicine and Therapeutic Nanotechnology.

Introduction/ Objective: Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovial joints, leading to joint destruction and systemic complications. Existing therapies, such as Disease-Modifying Antirheumatic Drugs (DMARDs) and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs),...

Ashok Thulluru, C. Jangme, Vrushabh Patil · 0 citations
Open access Oct 2026

Development of Triamcinolone Acetonide-Loaded Nanoparticles for Inflammatory Knee Arthritis Treatment

Introduction Intra-articular corticosteroid injections (IACIs) provide an alternative treatment for inflammatory arthritis. Nevertheless, IACIs are limited by adverse effects, including injection-related pain, corticosteroid-induced chondrocyte toxicity, and progressive cartilage degeneration following prolonged use. M...

Shu-Jyuan Yang, Tzu-Hao Tseng, Po-Ju Ting et al. · 0 citations
Open access Sep 2026

Folate-modified liposomal celastrol for rheumatoid arthritis: therapeutic efficacy and modulation of ROS/NF-κB/COX-2-related inflammatory signaling

Background Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by severe synovial inflammation, joint deformities, and progressive tissue destruction. Celastrol (Cel), a natural triterpenoid with anti-inflammatory and antioxidant activity, is a promising therapeutic candidate for RA; however, its a...

Ji-Quan Shen, Chang-Jian Zhou, Xing-Gao Wang et al. · 2 citations · ⚡1
Review Sep 2026

A Review Article on Smart Phyto-nanoemulgel Systems for Modulation of Inflammatory Mediators in Rheumatoid Arthritis.

This review article offers a thorough examination of nanoemulgel-based drug delivery methods for rheumatoid arthritis (RA) treatment. The study delves into the fusion of nanotechnology with gel-based systems, underscoring their superior drug-delivery capabilities, controlled release, and targeted therapeutic potential...

Renu Tiwari, Shaweta Sharma · 0 citations
Review Open access Sep 2026

Nanomedicine Approaches for Rheumatoid Arthritis (RA): Targeted Therapy and Controlled Drug Release

Advanced nanomedicine represents a promising strategy for improving the safety, efficacy, and personalization of rheumatoid arthritis treatment and holds significant potential for transforming future clinical management of this debilitating autoimmune disease.

P. Swami, Ajita S. Kesharwani · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.